ANTX
NASDAQ · Pharmaceuticals
An2 Therapeutics Inc
$5.93
-0.15 (-2.47%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+212.8% upside
Low Target
$11.23
Average Target
$18.55
High Target
$22.80
Current Price
$5.93
Current
$5.93
$5.93
Target
$18.55
$18.55
$11.23
$18.55 avg
$22.80
Scenario Analysis
Bear Case
$11.23
89.4%
Low target
Base Case
$18.55
+212.8%
Avg target
Bull Case
$22.80
+284.5%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$6.91
-14.2% from high
52-Week Low
$1.00
+493.0% from low
Target vs 52W High
$18.55
+168.5% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.28
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals